News

October 26, 2022
Medical Research

AMRA Medical at AASLD 2022: Premier MRI Technology and Informatics for The Full Continuum of Liver Disease

AMRA Medical’s MRI-based technology and informatics are featured in seven abstracts accepted for presentation at The Liver Meeting 2022 – the world’s “must-attend” hepatology…
Read More
September 21, 2022
Medical Research

AMRA Medical at EASD 2022 Conference: Two Abstracts Paving A New Path For Research With The Two Largest Diabetes Companies

AMRA Medical’s cutting-edge technology for body composition assessment was used in two separate studies for evaluating the effects of diabetes drugs—one being Lilly’s Tirzepatide,…
Read More
August 23, 2022

AMRA Medical Pivots — Both In Look and Focus

AMRA Medical launches a new brand identity and logo to align with its clinical focus….
Read More
July 13, 2022
Medical Research

Fulcrum Phase 3 FSHD Clinical Trial Using AMRA Medical’s Whole-body MRI Measurements as a Key Secondary Endpoint

REACH, a Phase 3 Clinical Trial of losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) utilizes AMRA’s Muscle Fat Infiltration (MFI) as a secondary endpoint. AMRA…
Read More
July 5, 2022
Medical Research

AMRA Medical continues to advance FSHD research with whole-body MRI measurements

AMRA’s recent publication demonstrates the utility of MRI-based muscle composite scores in neuromuscular disease clinical trials. AMRA Medical, a digital health company delivering a…
Read More
June 23, 2022
Medical Research

AMRA Biomarkers Indicate Individuals with CVD and T2D Have Faster Muscle Deterioration than Metabolically Disease-Free People — AMRA Medical to Present Data at SCWD

AMRA Medical will present “Two years of aging – initial results on changes in muscle composition in the UK Biobank imaging study” at SCWD,…
Read More
June 13, 2022
Medical Device

Human Longevity, Inc. adds AMRA® BCP Scan by AMRA Medical to the world’s most advanced precision longevity care program

AMRA Medical today announced they have signed a definitive agreement with Human Longevity Inc. (HLI) to offer AMRA® BCP Scan Report to its members…
Read More
June 1, 2022
Medical Device

AMRA Webinar. From BMI to BCP: Body Composition Profiling with MRI for Metabolic Disease Management, Health Risks & Healthy Lifestyle Choices

In the search to understand metabolic disease, prevention and treatments, people are often broadly categorized using relatively crude tools. This removes the individualized perspective….
Read More
May 31, 2022
Medical Device

AMRA®MAsS Scan – Introducing an Objective Way to Help Clinicians Assess Muscle Health at ATC 2022

AMRA will be in Boston for the American Transplant Congress (ATC 2022) on June 4 – 8. We will be happy to meet with…
Read More
April 26, 2022
Medical Research

AMRA Medical’s MRI-based body composition measurements used in Lilly’s SURPASS-3 tirzepatide sub-study

Eli Lilly and Company assessed the impact of tirzepatide, an investigational therapy for the treatment of type 2 diabetes, on liver fat, visceral fat,…
Read More
By using our site, you acknowledge that you have read and understood our privacy policy. We use cookies to ensure you have the best browsing experience on our website.
Accept & Close